Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
First published online on July 18, 2008
Chest, doi:10.1378/chest.08-0344
doi:10.1378/chest.08-0344
(Chest. 2008; 134:789-793)
© 2008 American College of Chest Physicians
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
chest.08-0344v1
134/4/789    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Gibson, N. S.
Right arrow Articles by Buller, H. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gibson, N. S.
Right arrow Articles by Buller, H. R.

The Importance of Clinical Probability Assessment in Interpreting a Normal d-Dimer in Patients With Suspected Pulmonary Embolism

Nadine S. Gibson, PhD*; Maaike Sohne, PhD; Victor E. A. Gerdes, PhD; Mathilde Nijkeuter, PhD and Harry R. Buller, PhD

*From the Department of Vascular Medicine (Drs. Gibson, Sohne, Gerdes, and Buller), Academical Medical Center, Amsterdam, the Netherlands; and the Department of General Internal Medicine (Dr. Nijkeuter), Leiden University Medical Center, Leiden, the Netherlands.

Correspondence to: Nadine Gibson, PhD, Department of Vascular Medicine, Academical Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; e-mail: n.s.gibson{at}amc.uva.nl

Background:The d-dimer test is widely applied in the diagnostic workup of patients with suspected pulmonary embolism (PE). The objective of this study was to investigate how often the d-dimer test fails when clinical probability is not taken into account.

Methods:We used data collected in 1,722 consecutive patients with clinically suspected PE to analyze the 3-month venous thromboembolism (VTE) rate in all patients with a normal d-dimer concentration and separately for patients who have a normal d-dimer concentration with an unlikely or likely clinical probability for PE, as assessed by the Wells clinical decision rule.

Results:The 3-month VTE rate in all patients with a normal d-dimer concentration (n = 563) was 2.3% (95% confidence interval [CI], 1.4 to 3.9%). In the patients with an unlikely probability of PE (n = 477), VTE was confirmed in 1.1% of the patients with a normal d-dimer concentration (95% CI, 0.4 to 2.4%). In those patients with a likely clinical probability of PE (n = 86), VTE was confirmed in 9.3% of the patients with a normal d-dimer concentration (95% CI, 4.8 to 17.3%). The difference in VTE incidence between patients with unlikely and likely clinical probabilities of PE was significant (p < 0.001).

Conclusions:Our findings indicate that it is of utmost importance to first examine the patient and assess the clinical probability, after which the d-dimer concentration can be taken into account, in order to prevent physicians from being influenced by a normal d-dimer test result when they evaluate the clinical probability of PE. Patients with a likely clinical probability should undergo further testing, regardless of the d-dimer test outcome.

Key Words: deep venous thrombosis • pulmonary embolism • thrombosis

Abbreviations: CDR, clinical decision rule • CI, confidence interval • DVT, deep venous thrombosis • IQR, interquartile range • LMWH, low-molecular-weight heparin • PE, pulmonary embolism • VTE, venous thromboembolism







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American College of Chest Physicians.